The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...
New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
Pharmaceutical Technology on MSN
Eli Lilly buys Adverum in eye disease gene therapy punt
Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...
Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...
The Chosun Ilbo on MSN
Samsung Backs U.S. Gene-Editing Firm Arbor Bio
Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...
The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results